Los Angeles Biotechnology Network
Advertise With Biotech Networks
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ September 23, 2023 ] Principal Scientist (Tumor Microenvironment Research & Operations) – Ellison Institute – Los Angeles, CA Los Angeles Biotech Jobs
  • [ September 23, 2023 ] Sr. Scientist(Animal model,Molecular Biology,ELISA,Tissue Collections) – Tellus Solutions – Irvine, CA Los Angeles Biotech Jobs
  • [ September 23, 2023 ] Lead QA Technician – Takeda Pharmaceutical – Los Angeles, CA Los Angeles Biotech Jobs
  • [ September 22, 2023 ] Microbiologist I – Curia – Camarillo, CA Los Angeles Biotech Jobs
  • [ September 22, 2023 ] Technical Writer – PSC Biotech – Pomona, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsSTAT+: Pharmalittle: Winners and losers from Medicare drug-negotiation list; Novo strikes deal to keep lead in weight-loss drugs

STAT+: Pharmalittle: Winners and losers from Medicare drug-negotiation list; Novo strikes deal to keep lead in weight-loss drugs

August 30, 2023 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on STAT+: Pharmalittle: Winners and losers from Medicare drug-negotiation list; Novo strikes deal to keep lead in weight-loss drugs

On Tuesday, the U.S. government named 10 medicines that will be subject to Medicare price negotiations in 2026.
Click here to view original post

Previous

Handful of biotechs expected to IPO this fall, but many are stuck in ‘holding pattern’ until 2024

Next

Advance Meta-omics Analysis for Biotechnology and Planetary Protection Efforts – National Aeronautics and Space Administration (NASA) – Pasadena, CA

Follow/Subscribe

Advertise With Biotech Networks
POST A JOB
Tweets by LABioNetwork
Advertise With Biotech Networks

Copyright © 2023 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered